We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TTE:NYSETotalEnergies SE Analysis

Data as of 2026-09-06 - not real-time

$88.59

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind TotalEnergies SE is bullish at $88.59, with short-term averages leading the long-term ones. The last 30 days have gained 2.1%. Relative strength is 53.7 — neutral — and the MACD signal is bearish. The recent range runs from support at $85.79 up to resistance at $92.16.
Multiples put this in undervalued territory: 11.1 times earnings against the sector's 17.8. Analyst price targets sit 8.6% above the current price. Revenue is growing at 27.8% on a 9.1% profit margin. The 4.78% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 22.6%, a beta of -0.24 and a maximum drawdown of 20.1%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.

Top Market Events

TotalEnergies SE NYSE:TTE reported second-quarter adjusted net income of $6 billion on July 23, 2026, up 67%...Regulatory News: The financial report of TotalEnergies SE Paris:TTE LSE:TTE NYSE:TTE for the first half 2026 was filed...Yahoo Finance1monTotalEnergies SE TTE Q2 FY2026 earnings call transcriptTotalEnergies delivered a strong Q2 2026 with...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 80.52
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 11.1 versus sector average of 17.8
  • Trading above the 200-day average of 80.52

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 11.1 versus sector average of 17.8
  • Analyst targets imply +8.6% versus the current price
  • Revenue growth of +27.8%

Key Metrics & Analysis

Financial Health

Revenue Growth27.80%
Profit Margin9.08%
P/E Ratio11.1
ROE14.48%
ROA5.51%
Debt/Equity48.05
P/B Ratio1.5
Op. Cash Flow$33.0B
Free Cash Flow$13.5B
Industry P/E17.8

Technical Analysis

TrendBullish
RSI53.7
Support$85.79
Resistance$92.16
MA 20$88.62
MA 50$84.60
MA 200$80.52
MACDBearish
VolumeIncreasing
Fear & Greed Index95.48

Valuation

Fair Value$196.92
Target Price$96.20
Upside/Downside8.59%
GradeUndervalued
TypeBlend
Dividend Yield4.78%

Risk Assessment

Beta-0.24
Volatility22.58%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.